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Abstract 
Compounds containing the pyrrole ring as a core structural motif continue to show 
significant biological activity, and both natural product derivatives and novel chemical scaffolds 
show potential for use as pharmaceuticals in treating a variety of cancers, infections, and 
inflammation. Given the widespread and important applications of compounds containing this 
motif, novel, rapid, and selective methods for the synthesis of multifunctional pyrroles is of some 
importance. Previous work in our group has utilized palladium-mediated Suzuki cross-coupling 
as a powerful tool for functionalizing activated bromopyrrole esters, generating structural 
analogues of bioactive natural products. We have also used a similar approach to synthesize a 
novel class of microtubule polymerization inhibitors that have potential as future antitumor 
agents. Herein we describe methods for the selective modification of the C3 and C5 positions on 
the pyrrole ring, which have modified and expanded upon the previous work using cross-
coupling and other common methods, to improve synthetic flexibility and broaden the scope of 
these reactions. I also show application to the synthesis of new derivatives of Lycogarubin C 
natural product, as well as preparation of novel microtubule-inhibiting agents as part of a 
structure-activity relationship study (SAR) for development of new cancer chemotherapeutics. 
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Introduction 
Highly substituted heterocycles are common chemical motifs that are at the core of 
numerous essential pharmaceuticals and a number of naturally occurring molecules, which 
themselves have interesting biological activity or which have been chemically modified for 
commercial use. Consequently, the preparation of substituted heterocyclic compounds is of great 
interest to synthetic chemists. Compounds containing the pyrrole motif, a five-membered, 
nitrogen-containing aromatic heterocycle, are of particular interest due to the large number of 
bioactive pyrrole-containing natural products, including the Polycitones (1) (which exhibit anti-
HIV-1 integrase activity)1, Lycogarubin C (2) (a biosynthetic precursor to the protein kinase 
inhibitor rebeccamycin)2, and the Rigidins (3) (calmodulin antagonists)3. Some examples of 
pyrrole natural products are shown in Figure 1. 
 
Figure 1. Polysubstituted pyrrole natural products include the Polycitones (1) A (X=p-OH-phenethyl) and B (X=H); 
Lycogarubin C (2); and the Rigidins (3) A-E (X=Y=H or MeO, Z=H or Me). 
 
Additionally, commercial drugs, such as those in Figure 2, that contain a pyrrole ring as a 
core structural element include the cholesterol treatment atorvastatin (aka Lipitor) (4), as well as 
the cyclooxygenase-2 (COX2) inhibitor ketorolac (5), and sunitinib (6), a receptor tyrosine 
kinase inhibitor used in the treatment of renal and gastrointestinal cancer. 
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Given the importance of these and other pyrrole-containing compounds, synthetic 
methods that generate large quantities of pure material and that are stereoselective, require 
inexpensive reagents, and utilize mild reaction conditions and minimal purification are key to the 
rapid production and study of these compounds. The multi-step nature of these syntheses, 
however, frequently results in methods that require purification at each stage of preparation and 
low overall yields, where several grams of starting materials yield only a few milligrams of pure 
product. In addition, the need to selectively modify one functional group while leaving the rest of 
the molecule unchanged leads to the use of protecting groups, which both increases the total 
number of stages in the synthesis and the amount of waste generation. 
 
Figure 2. Cholesterol-lowering atorvastatin (Lipitor) (4), COX-2 inhibitor ketorolac (5), and cancer therapeutic 
sunitinib (6) are all pyrrole-containing pharmaceuticals. 
 
One way to reduce the waste associated with long multistep syntheses is to build smaller 
pieces of the overall structure separately and them bring them together in the middle of the 
synthetic process to generate the core target structure. When using such an approach, individual 
components, some of which might be commercially available, are faster and easier to prepare 
with minimal waste, and only small modifications may need to be made after the components are 
brought together to afford the compound of interest. The Gupton group has previously employed 
such a strategy to prepare Polycitones A and B, wherein an aromatic vinylogous quaternary 
iminium salt (7) and an α-aminoketone (8) are used to generate a compound (9) that in a few 
steps was converted (10) to a natural product precursor (Scheme 1)4.  
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Scheme 1. Previous work4 in the Gupton group utilized the reaction of a vinylogous iminium salt (7) and α-
aminoketone (8) to generate a disubstituted pyrrole (9), which was readily converted to a Polycitone precursor. 
 
The individual components are synthesized in 1 and 2 steps, respectively, from readily available 
materials in high yield, and the variety of different aromatic starting materials available means 
that analogous molecules with different substituents could be prepared.4 Similar methods have 
also been employed by the Gupton group to prepare Rigidin A and E3, and in both cases the 
natural products (or their precursors) were generated with regioselectivity and in fair overall 
yield. 
While this approach does have some advantages, it is limited in a key component of 
synthetic strategy: flexibility. Since the individual components are prepared from starting 
materials containing the groups present in the final product, for each desired change in the final 
product, a new starting material must be prepared and the entire synthetic process must be 
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carried out. This time-consuming process is particularly problematic in structure-activity 
relationship (SAR) studies, where small quantities of many different molecules, each containing 
slight modifications to the same core structure, are desired for biological screening. By using a 
highly flexible, easily synthesized intermediate that is several steps into the synthetic pathway, 
individual modifications can be made in smaller quantities without the need to restart the 
synthesis for each new analogue. This reduces both chemical waste and time needed to prepare 
such biologically active compounds, both of which translate into more economical syntheses. 
 
Scheme 2. The key intermediate ethyl 4-bromopyrrole 2-carboxylate (13) is easily prepared by 1) Bromination of 2-
trichloroacetylpyrrole (11) and 2) Esterification of the brominated starting material (12). While (13) does not 
undergo Suzuki cross coupling, the formylated BPE (14) is readily coupled with a variety of aromatic and 
heteroaromatic trifluoroborates to give disubstituted pyrroles (15). *Optimized Suzuki conditions, as reported5, are 1 
eq. (14), 1.2 eq. organoboron (boronic acid or trifluoroborate), 1.4 eq. DABCO, 5mol% Pd(II)dppf catalyst, and 
2mL water in a 9:3 toluene:ethanol solvent mix under microwave heating for 2hrs at 110°C. 
 
Recently the Gupton group has been interested in the applications of a flexible pyrrole 
building block, ethyl 4-bromopyrrole 2-carboxylate (13) (abbreviated “bromopyrrole ester” or 
BPE), as an intermediate in the synthesis of natural products and the generation of novel 
compounds with important biological activity. This intermediate, which can be prepared in 
multi-gram quantities from the commercially available 2-trichloroacetylpyrrole in a simple 2 step 
process requiring no purification (compounds 11 and 12), has already been shown5, when 
activated via formylation (14), to be an excellent substrate for Suzuki cross coupling. While the 
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unmodified BPE gave a gross mixture of materials under Suzuki conditions, the addition of the 
aldehyde group adjacent to the carbon-bromine bond (labeled C4 by convention, see Scheme 2) 
allowed the pyrrole to efficiently cross-couple with a variety of aromatic and heteroaromatic 
boronic acids in high yields (Scheme 2). 
In the Suzuki reaction mechanism, a bond is formed between an sp2-hybridized carbon 
with an attached leaving group (typically a halide) and the sp2-carbon on an organoboron 
species, such as a boronic acid, boronic acid ester, or trifluoroborate salt, through a palladium-
catalyzed cycle. The first step in this process, the oxidative addition of the palladium (Pd0 to 
Pd(II)) between the carbon and its attached leaving group, requires polarization of the carbon-
halogen bond. In an electron-rich ring system such as a pyrrole, the additional electron density 
lowers the polarization of this bond, reducing reactivity. Through the addition of an electron-
withdrawing group, such as an aldehyde, on the adjacent carbon, that electron density is pulled 
away from the carbon-halogen bond, restoring the reactivity and allowing the pyrrole to undergo 
oxidative addition. This first step in the mechanism is rate-determining6, so once the oxidative 
addition has occurred, the remaining steps, transmetallation of the Pd(II) complex with the 
organoboron (which transfers the carbon-containing group from the boron to the Pd(II) complex) 
and reductive elimination of the palladium (which forms the new carbon-carbon sigma bond and 
restores the catalyst to Pd0) can proceed to completion. 
Not only does the aldehyde group serve to activate the BPE toward cross coupling, but it 
is also a highly reactive group that can be modified in numerous ways to introduce a wide variety 
of functional groups at that position (C5) on the pyrrole ring. Since this formylbromopyrrole 
ester intermediate has flexibility at both the C4 (via cross coupling) and C5 (via aldehyde 
modification), it has the potential to be a powerful tool in SAR studies. Furthermore, many of the 
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important natural products have carbonyl groups at C5 and aromatic or heteroaromatic groups at 
C4, meaning that this intermediate also has the potential to be used in the development more 
efficient syntheses of these compounds. 
Since previous members of the Gupton group had shown the application of aldehydes as 
activating groups for pyrrole cross coupling, the aim of the present research was two-fold. First, 
to examine the ability of other electron withdrawing groups to activate BPE toward cross 
coupling, increasing the potential of such methods for natural product synthesis. Second, to 
determine the synthetic flexibility of the C5 and C3 positions of the pyrrole, with the aim of 
generating novel pyrrole-containing compounds for biological SAR study. Throughout this work, 
we examined the scope of reactivity of our BPE intermediate and limitations relevant to 
commercial or biological application, including improved yield, simplified purification, and 
reduced waste. 
Results and Discussion 
Electron Withdrawing Group Activation in Suzuki Cross Coupling 
In an effort to expand the range of activating groups used in Suzuki coupling of BPE, two 
chemically and structurally distinct groups were examined first for their ease of synthesis, and 
second, for their ability to activate the pyrrole toward coupling. The first group installed was a 
aromatic ketone, containing a motif common in some pyrrole-containing natural products. Initial 
attempts to acylate BPE with p-methoxyphenylbenzoic acid, trifluoroacetic acid, and 
trifuoroacetic anhydride proved complicated and did to go to completion. Since the formation of 
the acylium cation requires the formation of a mixed acid anhydride, followed by loss of 
trifluoroacetate (a good leaving group), we decided to see if using an acid anhydride that would 
generate a stronger leaving group might improve the conversion of this reaction (Scheme 3).  
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Scheme 3. Acylation of BPE results in activation of BPE towards Cross Coupling. Acylation with 2 eq. of 
benzoic acid and 4 eq. of triflic anhydride gave high-yielding p-methoxybenzoylpyrrole (16) that required no further 
purification prior to cross coupling. Using previously described Suzuki cross coupling conditions, the acylpyrroles 
were coupled to a range of aromatic boronic acids to give trisubstituted pyrroles (17a-b). 
 
Trifluoromethanesulfonic (triflic) anhydride, which generates the much stronger triflate (-OTf) 
leaving group, was used in place of the TFAA and TFA reagents. Although pure triflic anhydride 
can be quite difficult to work with due to its violent reactivity with water and corrosive 
properties, it is readily available in an easy-to-handle 1M solution in dichloromethane, allowing 
us to store it and use it safely, with minimal additional waste. 
Reacting one equivalent of the 
BPE starting material with two 
of the p-methoxyphenyl 
benzoic acid and for of the 
anhydride in dichloromethane 
overnight at room temperature 
yielded a dark colored solid 
that appeared by NMR to be the acylated bromo pyrrole ester at near analytical purity. As such, 
it was used in forthcoming cross coupling reactions without further purification. Two analogues 
were tested for their ability to be coupled to acylated BPE using the standard conditions 
previously determined for the aldehyde. In both cases the analogues (4-methoxyphenyl and 3,4-
dimethoxyphenyl) were chosen because highly oxygenated phenyl groups are common motifs in 
N
H
Br
O
O
4-MeOPhCO2H
(F3CSO2)2O
DCM, RT 24 hrs NH
Br O
O
O
O
ArB(OH)2, DABCO
5mol% Pd(II)dppf
9:3:2 tol:EtOH:H2O
MW 110oC 2hrs
N
H
Ar O
O
O
O
(13) (16) (17a): Ar = 4-methoxyphenyl
(17b): Ar = 3,4-dimethoxyphenyl
Table 1. Both the acylated and nitrile BPE compounds underwent cross coupling 
with boronic acids containing highly oxygenated phenyl rings in good to excellent 
yield. 
  
 8 
naturally-occurring compounds that are biologically active. In both cases, cross coupling 
proceeded in good yield after purification by flash chromatography (see Table 1). 
 After establishing the feasibility of acyl ketones as activating groups, we examined how a 
nitrile, also electron withdrawing but with vastly different steric properties, would act in 
coupling (Scheme 4). Taking the formylated bromopyrrole ester (14) and refluxing it for 2 hours 
with hydroxylamine hydrochloride in pyridine and ethanol yielded a mixture of oxime isomers, 
which were easily separated by chromatography. The crude mixture of the oximes was 
dehydrated by addition of phosphorus (V) oxychloride in chloroform at room temperature 
yielding nitrile (19), which was not purified prior to cross coupling reactions, again with three 
highly oxygenated phenyl coupling agents (20-22). These reactions, summarized in Table 1, all 
proceeded in good to excellent yield, and were purified by flash chromatography to remove a 
small amount of side product, which was identified as the reduction product of the bromine to 
hydrogen. Currently we are exploring the optimization of these activating groups in cross 
coupling reactions of pyrroles as well as the viability of new electron withdrawing groups, to 
show the scope and versatility of the BPE as a flexible synthetic tool. 
 
Scheme 4. Nitrile groups are easily added to the BPE intermediate and activate it in Suzuki coupling. An 
oxime intermediate allows for the simple preparation of nitrile (18) from the formylated BPE without the need for 
purification between steps. The same optimized coupling conditions used for the original aldehyde paper and acyl 
group cross coupling. 
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Natural Product Analogues – Towards Structure-Activity Relationship Studies 
 One of the pyrrole-containing natural products of synthetic interest to the Gupton group 
is Lycogarubin C (2), a symmetric, tetrasubstituted pyrrole with indole rings and C3 and C4 and 
methyl esters at C2 and C5. Derived from the slime mold Lycogala epidendrum, Lycogarubin C 
is believed to be a biological precursor to the important bioactive alkaloids rebeccamycin and 
staurosporine2, and as such has a core structure that may be of interest in potential structure-
activity relationship (SAR) studies. In the previous study5 of formyl-group activation of BPE, an 
analogue with an N-phenyl-sulfonyl-3-indolyl moiety at C4 of the pyrrole was prepared; this 
reaction was again utilized in a Gupton group formal synthesis of the natural product. 
 
 
Scheme 5. Synthesis of asymmetric Lycogarubin C analogues, for potential use in SAR studies. The methyl 
ester intermediate was utilized since this functionality is present in the natural product. Three different aromatic 
analogues (28a-c) were prepared on small scale in fair to excellent yield. 
 
 The initial steps of the synthetic pathway, as shown in Scheme 5, are very similar to the 
preparation of BPE (13), except that the methyl ester was prepared, mimicking the native 
structure of Lycogarubin C. Formylation (25) and Suzuki cross coupling were conducted as 
previously described, except that instead of the boronic acid, the more readily available N-
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phenyl-sulfonyl-3-indolyl pinacol borane was used. (This compound gets converted to the 
boronic acid in situ). This cross-coupled aldehyde (26), which, in the total synthesis was 
converted to the methyl diester prior to further modification, became my substrate for 
examination of flexibility at the C3 position of the pyrrole. 
 Bromination of the pyrrole (26) at the C3 position was achieved under basic conditions 
using N-bromosuccinimide (NBS), a shelf-stable, easier-to-use source of bromine than liquid 
Br2. Under basic conditions, the amine proton of the pyrrole ring is abstracted, generating an 
enamine that has a significant resonance form at C3 with a formal charge of -1. This negative 
character to C3 means that Br+ is most likely to form a bond at this position, resulting in a highly 
selective reaction that produces no over-bromination byproducts. Bromoaldehyde (27) was then 
cross-coupled with three highly oxygenated phenylboronic acids (4-methoxyphenyl, 3,4-
dimethoxyphenyl, and 3,4,5-trimethoxyphenyl) to determine what chemical modularity can be 
achieved at the C3 position of the pyrrole ring. 
While cross-coupled products of (27) with 4-methoxyphenylboronic acid (28a) and 3,4,5-
trimethoxyphenylboronic acid (28c) showed excellent yields greater than 90%, the 3,4-
dimethoxyphenylboronic acid cross coupling (28b) had a significantly lower yield, 39%. This 
reaction, which was repeated under identical conditions to give almost an identical yield, was 
inexplicably lower than the other two couplings. Since all three examples had similar electronic 
characteristics (electron-rich) and since 3,4,5-trimethoxyphenylboronic acid is bulkier than 3,4-
dimethoxyphenylboronic acid, it seems unlikely that the difference in yield is due to differences 
in the structures. However, since these reactions were conducted on a small scale, it is possible 
that a small mistake in material transfer could lead to a significant effect in the final yield. 
Regardless of isolated yield, these experiments show how a bromopyrrole ester intermediate can 
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be used not only in an additional natural product synthesis, but also how the inherent flexibility 
of the BPE intermediate makes it perfectly suited for the generation of small amounts of many 
different analogues with the same core structure, a feature that proves invaluable during SAR 
study7. By using a bromopyrrole ester intermediate, the Polycitone, Rigidin, and Lycogarubin C 
natural products and associated analogues can be more easily and efficiently prepared. 
Modifications of a Biologically Active Pyrrole – Towards Structure-Activity Relationship Studies 
For several years the Gupton group, in collaboration with computational chemists at 
Virginia Commonwealth University (Kellogg group) and pharmacologists at The University of 
Texas Health Science Center at San Antonio (Mooberry group), have been developing and 
examining the biological activity of a class of novel pyrrole-based antitubulin agents using an 
SAR approach. These agents, which prevent the polymerization of tubulin into microtubules 
(cellular substructures essential to, among other processes, cell division), show promise as 
potential antitumor agents for the treatment of cancer. As previously mentioned, ethyl 4-bromo-
2-pyrrole carboxylate (13) is an ideal candidate for SAR due to its ease of preparation and high 
degree of synthetic flexibility, and recently the Gupton group has used BPE as a key building 
block in the preparation of new pyrrole-based antitubulin agents. 
Previous SAR studies on Gupton group compounds have shown that the optimum groups 
at C28 and C49 positions are, respectively, an ethyl ester and a 2,3,4-trimethoxyphenyl group. 
These studies gave rise to a parent compound, NT-7-16, which has bromine at both C3 and C5 
and exhibits inhibition of cancer cell growth at nanomolar concentrations. Based on 
computational modeling of these pyrroles in the colchicine binding site, it appears that C5 sticks 
out into the aqueous environment of the cell, which suggests that modifications at C5 that 
improve the hydrogen bonding capability of the molecule might help lock the pyrrole into a 
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high-affinity orientation, while simultaneously improving the overall water solubility of the 
compound. 
 
Scheme 6. 4 C5 analogues of NT-7-16 were prepared from a common intermediate prepared from BPE. 
Oxime (mix of isomers), nitrile, and 2 amines were all prepared in fair to good yield, as part of ongoing SAR study 
as potential microtubule inhibitors. 
 
Four compounds with potential water-solubilizing compounds have been synthesized 
(Scheme 6) and are currently undergoing biological testing. An oxime (31) was introduced by 
reaction of aldehyde (30) with hydroxylamine hydrochloride and pyridine in ethanol, in a high 
yield transformation that gave two distinct stereoisomers. The oxime mixture was dehydrated 
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with phosphorus (V) oxychloride to give the nitrile (32), also in good yield. In both these cases, 
the compounds did not require further purification prior to characterization, but were purified by 
chromatography to ensure purity for biological testing. A reductive amination strategy, using the 
same aldehyde starting material, was employed to add hydrogen-donating amine groups at C5 
attached by a one carbon linker. Since amines are typically protonated at physiological pH, it 
was hypothesized that introduction of these groups might greatly improve water solubility of 
these compounds. In a one-pot reaction, primary amines reacted with the aldehyde under mildly 
acidic conditions to generate an imine in situ, which as then reduced by sodium 
cyanoborohydride. This reducing agent was used due to its lower reactivity, to prevent reduction 
of the bromine at C3. Aminomethylene (33) and propylaminomethylene (34) compounds were 
prepared in modest yield. Upon purification, another product, identified as the reduced aldehyde, 
was isolated, indicating that the direct 
reduction of the aldehyde competes with the 
imine formation. Current work continues to 
optimize the reaction conditions for the 
preparation of the aminomethylene 
compounds, as well as to expand the range of groups substituted on the amine. 
All of these new compounds (Table 2) are undergoing the same range of biological 
testing that initially identified NT-7-16 as a key therapeutic target. Dr. Susan Mooberry and 
colleagues have reported9 typical procedures used for bioassay of these and other compounds, 
ranging from cell toxicity assays to microtubule binding and longer-term examinations of these 
compounds biological effects. 
 
Table 2. Four analogues of NT-7-16 were prepared with 
modifications at C5 in an effort to improve water solubility. Fair to 
good yields were obtained for all compounds. 
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Conclusions 
The bromopyrrole ester (BPE) intermediate has already been shown to be a highly 
flexible tool in Suzuki cross coupling, and herein I have described how two additional electron 
withdrawing groups can serve to activate this intermediate toward cross coupling, further 
showing the utility of the BPE building block in both potential natural product synthesis and 
pharmaceutical development. A further extension of these ideas showed how the rapid ability to 
generate analogues of the bioactive pyrrole natural product Lycogarubin C would prove useful 
during SAR studies, and this flexibility was employed in the preparation of novel analogues of 
NT-7-16, a potent microtubule inhibitor with potential as a cancer chemotherapeutic. In each of 
these cases the ease of preparation of the intermediate, and the flexible synthetic nature of the 
compound have revealed its efficacy as a powerful chemical tool for synthetic preparation of 
polysubstituted pyrroles. 
Experimental 
All chemicals were obtained from the manufacturer (Aldrich Chemicals or Fisher 
Scientific) and were used without modification. All solvents were dried over 4Å molecular 
sieves prior to use. NMR spectra were collected on either a Bruker 300MHz or 500MHz 
spectrometer in either CDCl3, DMSO-d6 or d6-acetone solutions. IR spectra were recorded on a 
Nicolet 320 FTIR spectrometer with HATR attachment. High resolution mass spectra were 
obtained on an LCMS-IT-TOF mass spectrometer at the University of Richmond. Low 
resolution GC-MS data were collected on a Shimadzu QP 5050 instrument. Melting points and 
boiling points are uncorrected. Chromatographic purifications were carried out on a Biotage 
Isolera or SP-1 instrument, both equipped with a silica gel cartridge. Gradient elution with ethyl 
acetate/hexanes was used on both instruments. TLC analyses were conducted on silica plates 
  
 15 
with ethyl acetate/hexanes as the eluent. All purified reaction products gave TLC results, flash 
chromatograms, and 13C NMR spectra consistent with greater than 95% sample purity. Presented 
in this experimental section are representative procedures and spectral data for each type of 
reaction presented in the text. 
4-bromo-5-(4-methoxybenzoyl)-1H-pyrrole 2-carboxylic acid ethyl ester (16): To a 100 mL 
round bottom flask was added 1.67 g p-anisic acid (11.0 mmol) and 30 mL of dry 
dichloromethane. To the flask was then added 22 mL triflic anhydride solution, 1 M in DCM 
(22.0 mmol) and the reaction stirred on ice bath 45 minutes. To the mixture was then added 1.20 
g of bromopyrrole ester (5.503 mmol). The reaction mixture was stirred at room temperature for 
20 hours. The reaction mixture was quenched with saturated sodium bicarbonate (100 mL) and 
the pH of this mixture was confirmed to be basic. This mixture was then extracted three times 
with dichloromethane. The organic layer was washed twice with brine, dried over magnesium 
sulfate, and concentrated in vacuo to give 1.11g of a dark solid (57.3% yield) which exhibited 
the following properties: m.p. 109-110°C; 1H NMR (acetone-d6, 300 MHz) δ  1.31 (t, J = 9 Hz, 
3H), 3.93 (s, 3H), 4.30 (q, J = 9 Hz, 2H), 6.98 (s, 1H), 7.07 (d, J = 6 Hz, 2H), 7.81 (d, J = 6 Hz, 
2H); 13C NMR (acetone-d6) δ  184.30, 164.60, 163.87, 159.24, 132.11, 129.91, 125.74, 117.79, 
113.73, 100.83, 60.67, 55.13, 13.65; IR (neat) 3249, 2363 and 1717 cm-1; HRMS (ES) calcd for 
C15H14NO4Br 350.0033 and 352.0015, found 350.0030 and 352.0014. 
 
5-(4-methoxybenzoyl)-4-(4-methoxyphenyl)-1H-pyrrole 2-carboxylic acid ethyl ester (17a): 
Bromo pyrrole ester (0.530 mmol, 0.187g), paramethoxyphenyl boronic acid (0.630mmol, 
0.0970 g), and 1,4-diazabicyclo[2.2.2]octane (DABCO; 0.740 mmol, 0.0833 g) were added to a 
20 mL, microwave vial fitted with a magnetic stir bar. To the reaction mixture was added toluene 
(9 mL) and ethanol (3 mL), after which dichloro-1,1,-bis(diphenylphosphino)ferrocene pallad-
ium (II) (0,027mmol, 0,0194g) was stirred into the solution. Twenty drops of reverse osmosis 
water were then added to the microwave vial which was then capped and microwaved for 2 
hours at 110°C with 30 seconds of pre-stirring. After the reaction was completed and allowed to 
cool, the reaction mixture was poured through a silica plug and rinsed with 3x20 ml of ethyl 
acetate and the filtrate was evaporated in vacuo. The resulting light brown solid had a mass of 
0.252g (125%). The crude product was flash purified twice on a 10g silica column with a 50:50 
gradient of hexane/ethyl acetate yielding a product with a mass of .105g (49.8% yield), with the 
following properties: m.p. 96-97°C; 1H NMR (acetone-d6, 300 MHz) δ  1.31 (t, J = 9 Hz, 3H), 
3.70 (s, 3H), 3.90 (s, 3H), 4.30 (q, J = 9 Hz, 2H), 6.98 (s, 1H), 6.74 (d, J = 9 Hz, 2H), 6.78 (d, J = 
9 Hz, 2H) 7.18 (d, J = 9 Hz, 2H), 7.61 (d, J = 9 Hz, 2H); 13C NMR (acetone-d6) δ  185.93, 
163.21, 160.02, 158.72, 131.88, 130.32, 130.23, 130.17, 130.13, 127.10, 125.11, 115.05, 113.47, 
113.25, 60.31, 54.97, 54.58, 13.75; IR (neat) 1709 and 1614 cm-1; HRMS (ES) calcd for 
C22H21NO5 402.1312, found 402.1294. 
 
4-bromo-5-(hydroxyiminomethyl)-1H-pyrrole 2-carboxylic acid ethyl ester (18): To a 100ml 
round-bottomed flask fitted with magnetic stirring bar and reflux condenser were added 4-
bromo-5-formyl-1H-pyrrole-2-carboxylic acid ethyl ester (0.05 g, 2.03 mmol), hydroxylamine 
hydrochloride (0.14 g, 2.03 mmol), pyridine (0.2 mL) and ethanol (20 ml). The mixture was 
  
 16 
heated at reflux for 2 hours, cooled to room temperature, and the solvent removed by rotary 
evaporation. The crude residue was dissolved in deionized water (15 mL) and extracted 3 times 
with 10 mL portions of ethyl acetate. The combined organic layer was washed with brine (10 
mL), dried over anhydrous sodium sulfate, filtered, and the solvent removed in vacuo to give 
0.51 g (a 98% yield) of a brown solid identified as 4-bromo-5-(hydroxyimino methyl)-
1Hpyrrole-2-carboxylic acid ethyl ester. While this material was pure enough for further 
synthesis, an analytical sample was prepared via flash chromatography yielding the syn (0.21 g, 
a 39% yield, fractions 8-10) and anti (0.22 g, a 43% yield, fractions 5-7) isomers, which 
exhibited the following spectral properties:  syn-isomer: m.p. 115-117°C, 1H NMR (CDCl3, 300 
MHz) δ  1.36 (t, J = 9 Hz, 3H), 4.34 (q, J = 9 Hz, 2H), 6.94 (d, J = 3 Hz), 8.14 (s, 1H), 9.91 (s br, 
1H); 13C NMR (CDCl3) δ  160.11, 140.71, 125.89, 124.56, 118.07, 102.20, 61.56, 14.37, 14.25; 
IR (neat) 3217, 2990 and 1682 cm-1. HRMS (ES) calcd for C8H9N2O3Br 260.9869 and 262.9850; 
found 260.9874 and 262.9841. anti-isomer: m.p. 105-107°C; 1H NMR (CDCl3, 300 MHz) δ  
1.39 (J = 6 Hz, 3H), 4.35 (q, J = 6 Hz, 2H), 6.93 (d, J = 3 Hz, 1H), 7.53 (s, 1H), 10.81 (s br, 1H); 
13C NMR (CDCl3) δ  160.17, 135.85, 125.14, 124.52, 116.84, 102.72, 61.39, 61.35, 14.28; IR 
(neat) 3440, 3133 and 1709 cm-1; HRMS (ES) calcd for C8H9N2O3Br 260.9869 and 262.9850; 
found 260.9874 and 262.9841. 
 
4-bromo-5-cyano-1H-pyrrole 2-carboxylic acid ethyl ester (19): To a round bottom flask 
equipped with magnetic stirring bar, addition funnel and rubber septum was added 4-bromo-5-
(hydroxyimino-methyl)-1H-pyrrole-2-carboxylic acid ethyl ester (0.50 g, 1.92 mmol) dissolved 
in anhydrous chloroform (20 mL), and stirred on an ice bath for 5 minutes. Phosophorus (V) 
oxychloride (0.29 g, 1.92 mmol) was dissolved in a further 10 mL of anhydrous chloroform, and 
added dropwise to the stirring solution over a period of 10 minutes. The addition funnel and ice 
bath were removed, and the reaction allowed to stir at room temperature overnight, The mixture 
was quenched with deionized water (30 ml), the phases were separated, and the organic layer 
was washed with brine (15 mL), dried over anhydrous sodium sulfate, and filtered. The solvent 
was removed in vacuo to give 0.370g of a red solid, which was further purified on a Biotage 
Isolera flash chromatography system (hexanes/ethyl acetate gradient) to give 0.329g (71% yield) 
of a yellow solid, 4-bromo-5-cyano-1H-pyrrole-2 carboxylic acid ethyl ester, which exhibited the 
following properties: m.p. 131-133°C 1H NMR (CDCl3, 300 MHz) δ  1.42 (t, J = 6 Hz, 3H), 4.43 
(q, J = 6 Hz, 2H), 6.94 (d, J = 6 Hz, 1H), 10.91 (s br, 1H); 13C NMR (CDCl3) δ  159.83, 127.06, 
117.16, 111.29, 107.95, 107.02, 62.48, 14.18; IR (neat) 3189, 3126, 2230 and 1692 cm-1; HRMS 
(ES) calcd for C8H7N2O2Br 240.9600, found 240.9618. 
 
5-cyano-4-(4-methoxyphenyl)-1H-pyrrole 2 carboxylic acid ethyl ester (20): Into a 20ml, 
microwave vial equipped with a magnetic stirring bar and a crimping cap was added 4-bromo-5-
cyano-1Hpyrrole-2-carboxylic acid ethyl ester (0.823 mmol, 200 mg), 4-methoxyphenyl boronic 
acid (0.987 mmol, 150 mg), 1,4diazabicyclo[2.2.2]octane (1.15 mmol, 130 mg), dichloro-1,1,-
bis(diphenylphosphino)ferrocene palladium (II) (0.042 mmol, 31 mg) along with toluene (9 mL), 
ethanol (3 mL) and water (2 mL). The reaction mixture was heated for 2 hours at 110°C in a 
Biotage Initiator microwave system. The reaction mixture was filtered through a short silica gel 
plug in vacuo with ethyl acetate (25 mL), dried over anhydrous sodium sulfate and concentrated 
in vacuo to give a dark brown crude residue (0.39 g, 178% yield).The crude residue was 
subjected to flash chromatographic purification on a Biotage isolera system with a SNAP 25 g 
silica column in which case a light yellow solid was obtained (0.20 g, 91% yield). It had the 
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following properties: m.p. 105-106°C; 1H NMR (CDCl3, 300 MHz) δ  1.42 (t, J = 6 Hz, 3H), 
3.87 (s, 3H), 4.39 (q, J = 6 Hz, 2H), 6.98 (d, J = 9 Hz, 2H), 7.07 (d, J = 3 Hz, 1H), 7.62 (d, J = 9 
Hz, 2H), 9.61 (s br, 1H); 13C NMR (CDCl3) δ  160.08, 159.75, 135.42, 128.03, 127.14, 124.18, 
114.47, 113.75, 112.90, 101.17, 61.82, 55.36, 14.29; IR (neat) 3240 and 2214 cm-1; HRMS (ES) 
calcd for C15H14N2O3 269.0932, found 269.0979. 
 
4.1.1 Methyl 3-Bromo-2-formylpyrrole-5-carboxylate (24): Into a 100 mL round bottom flask 
equipped with magnetic stirring and a rubber septum cap was placed 10 mL of anhydrous 
dichloromethane, 1.61 g (0.022 mol) of dry DMF, 2.90 g (0.019 mol) of phosphorus oxychloride 
and the resulting mixture was stirred in an ice bath for 10 mins. To this flask was then added 
1.28 g (0.0063 mol) of methyl 4-bromopyrrole-2-carboxylate in 10 mL of anhydrous 
dichloromethane and the resulting mixture was stirred overnight at room temperature. The 
reaction was worked up by the addition of 50 mL of water and separation of the two phases. The 
aqueous phase was extracted with additional dichloromethane (3 x 15 mL) and the combined 
dichloromethane phases were washed with brine (1 x 15 mL), dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo  to yield 1.20 g (82% yield) of a light brown solid. 
This material was of sufficient purity to be used in subsequent experiments but an analytical 
sample was prepared by purification via flash chromatography on a Biotage Isolera system in 
which case a light colored solid was obtained, which exhibited the following physical properties: 
mp 169-172 °C; 1H NMR (CDCl3) δ  9.75 (s, 1H), 6.97 (d, J = 3.0 Hz, 1H) and 3.94 (s, 3H); 13C 
NMR (CDCl3) δ  179.3, 159.9, 130.7, 127.5, 117.9, 107.8 and 52.5; IR (neat) 1704 and 1663 cm-
1; HRMS (ES) calcd for C7H7BrNO3 231.9609, found 231.9609. 
 
4.1.2 4-(1-Benzenesulfonyl-1H-indol-3-yl)-5-formyl-1H-pyrrole-2-carboxylic acid methyl 
ester (25): Into a 20 mL microwave reaction tube containing a stir bar was placed methyl 3-
bromo-2-formylpyrrole-5-carboxylate (0.250 g, 1.22 mmol), 1-(phenylsulfonyl)-3-
indolylboronic acid pinacol ester (0.468 g, 1.22 mmol), DABCO (0.160 g, 1.43 mmol) along 
with 9 mL of toluene and 3 mL of ethanol. After stirring the resulting mixture for several 
minutes, dichloro[1,1’-bis-(diphenyl-phosphino)ferrocene]palladium(II) dichloromethane adduct 
(0.037 g, 0.031 mmol) was added to the microwave reaction tube followed by the addition of 20 
drops of water and the tube was capped and sealed with a crimping tool. The reaction mixture 
was heated in a Biotage Initiator microwave system for 2 hrs at 110 °C. After cooling to room 
temperature, the reaction mixture was filtered through a short plug of silica gel and the silica was 
subsequently washed with 3 x 20 mL of ethyl acetate and the combined organic materials were 
concentrated in vacuo to give a dark solid (0.598 g). The solid was subjected to flash 
chromatographic purification on a Biotage Isolera system with a SNAP 25 g silica column in 
which case an orange-red solid was obtained (0.374 g, 90% yield). This material exhibited the 
following physical properties: mp 160-162 °C; 1H NMR (acetone-d6) δ  9.85 (s, 1H), 8.10-8.14 
(m, 4H), 7.68-7.73 (m, 2H), 7.62 (t , J = 6.3 Hz, 2H), 7.45 (t , J = 6.9 Hz, 1H), 7.36 (t , J = 6.9 
Hz, 1H), 7.20 (s, 1H) and 3.91 (s, 3H); 13C NMR (CDCl3) δ  185.0, 165.4, 143.1, 140.3, 139.6, 
136.9, 135.2, 134.9, 133.1, 132.2, 130.8, 130.4, 129.3, 129.2, 125.5, 120.9, 120.2, 118.9 and 
56.6; IR (neat) 1720 and 1658 cm-1; HRMS (ES) calcd for C21H16N2NaO5S 431.0678 found 
431.0641. 
 
4.1.7 4-(1-Benzenesulfonyl-1H-indol-3-yl)-3-bromo-5-formyl-1H-pyrrole-2-carboxylic acid 
methyl ester (26): Into a 100 mL round bottomed flask equipped with a magnetic stir bar was 
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placed 4-(1-benzenesulfonyl-1H-indol-3-yl)-5-formyl-1H-pyrrole-2-carboxylic acid methyl ester 
(.100 g, 0.245 mmol), KOH (0.014 g, 0.245 mmol) and 10 mL of DMF. The resulting mixture 
was stirred for 45 minutes and N-bromosuccinimide (0.087 g, 0.45 mmol), which had been 
dissolved in 5 mL of DMF, was added in one portion. The flask was covered with aluminum foil 
and the reaction mixture was stirred overnight at room temperature. The reaction was 
subsequently worked up by dilution with water (40 mL) and a 10% aqueous solution of sodium 
thiosulfate (20 mL) followed by extraction with ethyl acetate (3 x 15 mL). The combined organic 
phases were washed with brine (1 x 30 mL) and dried over anhydrous magnesium sulfate. After 
removal of the drying agent by filtration, the organic phase was concentrated in vacuo to yield a 
solid (0.340 g). This material was purified via flash chromatography on a Biotage Isolera system 
in which case a white solid (0.105 g, 89% yield) resulted. This material exhibited the following 
physical properties: mp 211-213 °C; 1H NMR (acetone-d6) δ  9.57 (1H), 8.10-8.12 (m, 3H), 8.02 
(s, 1H), 7.71 (t, J = 7.2 Hz, 1H), 7.63 (t, J = 7.2 Hz, 2H), 7.40-7.48 (m, 2H), 7.31 (t, J = 8.7 Hz, 
1H) and 1.98 (s, 3H); 13C NMR (acetone-d6) δ  179.7, 158.3, 137.7, 134.9, 134.5, 131.5, 130.4, 
129.7, 129.6, 127.1, 127.0, 125.2, 125.1, 125.0,123.8, 121.0, 113.6, 113.0 and 51.5; IR (neat) 
1713 1672 cm-1; HRMS (ES) m/z calcd for C21H15N2NaO5SBr 508.9777 found 508.9729. 
 
4.1.8 4-(1-Benzenesulfonyl-1H-indol-3-yl)-5-formyl-3-(4-methoxyphenyl)-1H-pyrrole-2-
carboxylic acid methyl ester (28a): Into a 20 mL microwave reaction tube containing a stir bar 
was placed 4-(1-benzenesulfonyl-1H-indol-3-yl)-3-bromo-5-formyl-1H-pyrrole-2-carboxylic 
acid ethyl ester (0.080 g, 0.164 mmol), 4-methoxyphenylboronic acid (0.030 g, 0.197 mmol), 
DABCO (0.026 g, 0.230 mmol), dichloro[1,1’-bis-(diphenyl-phosphino)ferrocene]palladium(II) 
dichloromethane adduct (.006 g, 0.008 mmol), toluene (9 mL), methanol (3 mL) and water (5 
drops).  The resulting mixture was stirred and heated in a Biotage Initiator microwave system for 
2 hrs at 110 °C. After cooling to room temperature, the reaction mixture was filtered through a 
short plug of silica gel and the silica was subsequently washed with ethyl acetate (25 mL) and 
the combined organic phases were concentrated in vacuo to yield an orange solid. The crude 
product was purified via flash chromatography on a Biotage Isolera system in which case a 
yellow-orange solid (0.081 g, 96% yield) was obtained and exhibited the following physical 
properties: mp  75-78 °C; 1H NMR (acetone-d6) δ  9.61 (s, 1Η), 7.98 (d, J = 6.0 Hz, 1H), 7.90 (d, 
J = 8.4 Hz, 2H), 7.75 (s, 1H), 7.72 (t, J = 7.5 Hz, 1H), 7.59 (t,  J = 6.9 Hz, 2H), 7.28 (t, J = 8.1 
Hz 1H), 7.07-7.16 (m, 4H), 6.68 (d, J = 8.7 Hz, 2H), 3.77 (s, 3H) and 3.74 (s, 3H); 13C NMR 
(acetone-d6) δ 180.5, 160.4, 158.8, 137.7, 134.8, 134.3, 131.4, 131.3, 131.0, 129.7, 129.6, 127.0, 
126.8, 126.7, 125.0, 124.5, 123.9, 123.6, 120.5, 114.6, 113.4, 112.8, 54.5 and 51.1; IR (neat) 
1714 and 1666 cm-1; HRMS (ES) m/z calcd for  C28H22N2NaO6S 537.1091 found 537.1054. 
 
4-(2,3,4-trimethoxyphenyl)-5-formyl-1H-pyrrole 2-carboxylic acid ethyl ester (29): To a 
20mL microwave vial was added 4-bromo-5-formyl pyrrole 2-carboxylic acid ethyl ester (0.5 g, 
2.032 mmol), 2,3,4-trimethoxyphenyl trifluoroborate (0.723 g, 2.64 mmol), Pd 
tetrakis(triphenylphosphine) (0.023 g, 0.02 mmol), Hunig’s base (0.341 g, 2.664 mmol) in  
toluene (9 mL) and ethanol (3 mL) with 20 drops of water. The reaction mixture was 
microwaved at 110°C for 2 hours. After cooling the reaction to room temperature, it was filtered 
through a short silica plug and the resulting mixture was evaporated in vacuo. The crude product 
was dried using a Kugelrohr apparatus to give a reddish brown solid (0.75 g, 110%). The crude 
residue was subjected to flash chromatography on a Biotage SP-1 instrument with silica column 
in which case 0.51 g (75% yield) of a dark brown solid was obtained upon elution with seven 
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column volumes of hexane/ethyl acetate gradient. This solid exhibited the following properties: 
m.p. 138-140°C; 1H NMR (acetone-d6, 500 MHz) δ  1.36 (t, J = 7.2 Hz, 3H), 3.66 (s, 3H), 3.88 
(s, 3H), 3.91 (s, 3H), 4.36 (q, J = 7.2 Hz, 2H), 6.89 (d, J = 8.5 Hz, 1H), 6.96 (s, 1H), 7.11 (d, J = 
8.5 Hz, 1H), 9.63 (s, 1H); 13C NMR (acetone-d6) δ  180.3, 159.0, 154.6, 152.0, 142.4, 130.9, 
130.7, 126.7, 124.6, 117.1, 107.5, 104.9, 60.9, 60.4, 60.2, 55.5, 13.6; IR (neat) 1709 and 1660 
cm-1; HRMS (ES) m/z calcd for C17H19NO6 356.1105, found 356.1077. 
 
3-bromo-4-(2,3,4-trimethoxyphenyl)-5-formyl-1H-pyrrole 2-carboxylic acid ethyl ester 
(30): To a 100 mL round bottom flask equipped with a stir bar, was added 4-(2,3,4-tri 
methoxyphenyl)-5-formyl pyrrole 2-carboxyic acid ethyl ester (0.100 g, 0.300 mmol) and 
potassium hydroxide (0.034 g, 0.6 mmol) in 15 mL of DMF. The reaction mixture was allowed 
to stir for 15 minutes at room temperature, after which N-bromosuccinimide (0.053 g, 0.33 
mmol) was added and the reaction mixture was stirred overnight at room temperature. The 
reaction mixture was diluted with 30 mL water and 15 mL of sodium thiosulfate solution was 
added to the reaction mixture. The reaction misture extracted with ethyl acetate (3 x 15 mL). The 
combined ethyl acetate layers were dried over anhydrous sodium sulfate, filtered and 
concentrated to give a dark brown solid (0.12 g, 96%). This solid exhibited the following 
properties: m.p. 158–160 °C; 1H NMR (CDCl3) δ  1.43 (t, J = 7.2 Hz, 3H), 3.68 (s, 3H), 3.93 (s, 
3H), 3.94 (s, 3H), 4.45 (q, J = 7.2 Hz, 2H), 6.81 (d, J = 8.5 Hz, 1H), 7.04 (d, J = 8.5 Hz, 1H), 
9.45 (s, 1H); 13C NMR (CDCl3) δ  181.0, 159.5, 154.5, 151.8, 142.3, 131.2, 130.2, 126.7, 124.6, 
116.7, 107.2, 105.3, 61.6, 60.2, 56.0, 14.2; IR (neat) 1708 and 1660 cm-1; HRMS (ES) m/z calcd 
for C17H18NNaBrO6 434.0210, 436.0192 found 434.0199, 436.0186. 
 
cis/trans-3-bromo-4-(2,3,4-trimethoxyphenyl)-5-oximino-1H-pyrrole 2-carboxylic acid ethyl 
ester (31): To a 100 mL round bottom flask equipped with a stir bar, was added 4-(2',3',4' 
trimethoxyphenyl)-5-formyl-pyrrole-2-ethyl ester (0.13 g, 0.315 mmol), hydroxyl amine 
hydrochloride (0.022 g, 0.315 mmol), 0.1 mL of pyridine in 15 mL of ethanol. The reaction 
mixture was allowed to reflux for 2 hours. The reaction mixture was cooled and evaporated to 
give a crude residue. Water (10 mL) was added to the residue and the solution was cooled in an 
ice bath and stirred until the oxime crystallized. The solid was filtered and washed with water (2 
x 15 mL) and dried to give cis/trans-3-Bromo-4-(2,3,4-trimethoxyphenyl)-5 oximino-1H-pyrrole 
2-carboxylic acid ethyl ester, as an orange solid (0.091 g, 68 %):  This solid mixture was 
subjected to flash chromatography on Biotage Isolera instrument with a silica column in which 
case 0.04 g (30% yield) of the cis isomer and 0.045 g (34% yield) of the trans isomer. 
 
(cis-3-Bromo-4-(2,3,4-trimethoxyphenyl)-5-oximino-1H pyrrole 2-carboxylic acid ethyl ester) 
exhibited the following properties: m.p. 141 143 °C; 1H NMR (acetone-d6) δ  1.39 (t, J = 7.2 Hz, 
3H), 3.64 (s, 3H), 3.86 (s, 3H), 3.91 (s, 3H), 4.39 (q, J = 7.2 Hz, 2H), 6.87 (d, J = 8.4 Hz, 1H), 
6.93 (d, J = 8.4 Hz, 1H), 7.03 (s, 1H); 13C NMR (acetone-d6) δ  159.1, 1542, 1522, 1424, 1394, 
127.0, 126.69, 124.7, 120.9, 1184, 107.4, 105.2, 60.2, 60.1, 55.4, 13.7; IR (neat) 1710 cm-1; 
HRMS (ES) m/z calcd for C17H19NNaBrO3 449.0319, 451.0301; found 449.0314, 451.0296.  
 
(trans-3-Bromo-4-(2,3,4-trimethoxyphenyl)-5 oximino-1H-pyrrole 2-carboxylic acid ethyl ester) 
exhibited the following properties: m.p. 125–126 °C; 1H NMR (acetone-d6) δ 1.39 (t, J = 7.2 Hz, 
3H), 3.64 (s, 3H), 3.86 (s, 3H), 3.91 (s, 3H), 4.39 (q, J = 7.2 Hz, 2H), 6.88 (d, J = 8.4 Hz, 1H), 
6.93 (d, J = 8.4 Hz, 1H), 7.74 (s, 1H); 13C NMR (acetone-d6) δ  159.1, 154.2, 152.2, 142.4, 
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139.4, 127.1, 126.7, 124.8, 121.0, 118.4, 107.5, 105.2, 60.3, 60.1, 55.4, 13.7; IR (neat) 1710 cm-
1; HRMS (ES) m/z calcd for C17H19NNaBrO3 449.0319, 451.0301; found 449.0313, 451.0297. 
 
3-bromo-5-cyano-4-(2,3,4-trimethoxyphenyl)-1H-pyrrole 2-carboxylic acid ethyl ester (32): 
To a 100 mL round bottom flask equipped with a magnetic stir bar, was added 4 (2,3,4 
trimethoxyphenyl)-5-oximino-1H-pyrrole-2-carboxylic acid ethyl ester (0.100 g, 0.234 mmol) 
dissolved in 20 mL of anhydrous chloroform. The reaction mixture was allowed to cool in an ice 
bath for 5 minutes. Phosphorus oxychloride (0.036 g, 0.234 mmol) was dissolved in 10 mL of 
anhydrous chloroform and the resulting mixture was added dropwise to the reaction mixture. The 
reaction mixture was stirred in an ice bath for 30 minutes and overnight at room temperature. 
The reaction mixture was diluted with 30 mL of water. The organic layer was washed with water 
(3 x 25 mL) and brine (1x 15 mL), dried over anhydrous sodium sulfate, filtered, evaporated and 
dried to give a light brown solid. The crude product was purified using a s silica plug and eluting 
with 30 mL of hexane/ethyl acetate (1:1), evaporated and dried to give a golden solid (0.085g, 
89%). This solid exhibited the following properties: m.p. 173–176 °C; 1H NMR (CDCl3) δ  1.45 
(t, J = 7.2 Hz, 3H), 3.83 (s, 3H), 3.93 (s, 6 H), 4.45 (q, J = 7.2 Hz, 2H), 6.75 (d, J = 8.4 Hz, 1H), 
6.97 (d, J = 8.4 Hz, 1H); 13C NMR (CDCl3) δ 159.2, 154.8, 152.0, 1422, 133.0, 126.0, 1242, 
116.3, 111.9, 106.9, 104.9, 104.8, 62.1, 61.2, 61.2, 56.0, 14.2; IR (neat) 2221 and 1729 cm-1; 
HRMS (ES) m/z calcd for C17H17N2O5Br 409.0230 found 409.0283. 
 
3-bromo-5-(N-propylaminomethylene)-4-(2,3,4-trimethoxyphenyl)-1H-pyrrole 2-carboxylic 
acid ethyl ester (34): To a 100 mL round bottom flask equipped with a magnetic stir bar, was 
added 3 bromo-5-formyl-4-(2,3,4-trimethoxyphenyl)-1H-pyrrole 2-carboxylic acid ethyl ester 
(0.300 g, 0.73 mmol) and n-propyl amine (0.36 mL, 4.34 mmol) in 15 mL of THF. The reaction 
mixture was stirred for 1 hour after which sodium cyanoborohydride (0.068g, 1.095 mmol) and 
glacial acetic acid (0.5 mL) were added. The reaction mixture was stirred for 24 hours at room 
temperature after which the reaction mixture was diluted with 50 mL of water and was extracted 
with ethyl acetate (3 x 15 mL). The organic layers were combined, dried over anhydrous sodium 
sulfate and evaporated in vacuo. The crude product was dried using a Kulgelrohr apparatus to 
give 0.356 g of dark brown solid. The crude residue was subjected to flash chromatography on a 
Biotage SP-1 instrument with a silica column in which case 0.25 g (76%) of a pale yellow solid 
was obtained upon elution with 19 column volumes of hexane/ethyl acetate gradient. This solid 
exhibited the following properties: m.p. 143-145 °C; 1H NMR (CDCl3, 300 MHz) δ  0.91 (t, J = 
7.5 Hz, 3H), 1.41 (t, J = 7 Hz, 3H), 1.49 (hex, J = 7 Hz, 2H), 2.57 (t, J = 7 Hz, 2H), 3.60 (s, 3H), 
3.68 (m, 2H), 3.92 (s, 3H), 3.93 (s, 3H), 4.39 (q, J = 7.2 Hz, 2H), 6.75 (d, J = 8.7 Hz, 1H), 6.95 
(d, J = 8.7 Hz, 1H); 13C NMR (CDCl3) δ 160.1, 153.3, 152.3, 1422, 126.9, 119.7, 118.7, 107.1, 
104.9, 61.2, 61.1, 60.5, 55.9, 51.3, 44.93, 22.4, 14.4, 11.6; IR (neat) 1727 cm-1; HRMS (ES) m/z 
calcd for C20H29N2BrO5 479.1152, 481.1134; found 479.1837, 481.2068. 
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